Vvaan Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
as on 15-06-2024
- Paid Up Capital ₹ 6.04 Cr
as on 15-06-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.50 Cr
as on 15-06-2024
- Revenue 3.71%
(FY 2023)
- Profit -23.77%
(FY 2023)
- Ebitda 6.71%
(FY 2023)
- Net Worth -289.35%
(FY 2023)
- Total Assets -45.24%
(FY 2023)
About Vvaan Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 6.04 Cr.
The company currently has active open charges totaling ₹5.50 Cr.
Maneesh Jain and Arun Dubey serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC280593
- Company No.
280593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2016
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vvaan Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maneesh Jain  | Director | 09-Jan-2020 | Current |
| Arun Dubey | Nominee Director | 09-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of Vvaan Lifesciences.
Vvaan Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.71% increase. The company also saw a substantial fall in profitability, with a 23.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 289.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vvaan Lifesciences?
In 2023, Vvaan Lifesciences had a promoter holding of 24.16% and a public holding of 75.84%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Zenfold Sustainable Technologies Private Limited
Active 3 years 1 monthArun Dubey is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2023 | ₹5.00 Cr | Open |
Hdfc Bank Limited Creation Date: 01 Dec 2021 | ₹5.00 M | Open |
How Many Employees Work at Vvaan Lifesciences?
Vvaan Lifesciences has a workforce of 162 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vvaan Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vvaan Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
